系统性硬化症器官损伤累积与一年死亡率:一项前瞻性观察性研究
这项前瞻性单中心研究纳入75例系统性硬化症(SSc)患者,采用硬皮病临床试验联盟损伤指数(SCTC-DI)评估累积器官损伤并随访12个月全因死亡。SCTC-DI中位数为4(IQR 6),仅4例(5.3%)SCTC-DI≥13;12个月时4例死亡,基线SCTC-DI≥13与EQ-5D视觉模拟量表(VAS)与死亡相关。
要点
- 75例SSc患者中SCTC-DI中位数为4(IQR 6),仅4例(5.3%)为重度损伤(≥13)。
- SCTC-DI相关因素包括病程(β=0.276)、mRSS(β=0.287)、CRP(β=0.311)与EQ-5D(β=-0.207)。
- 12个月死亡4例,基线SCTC-DI≥13(OR 44.5,95%CI 1.6-1237.9;p=0.025)与EQ-5D VAS(OR 0.9,95%CI 0.8-0.9;p=0.018)与死亡相关。
核心结论
- SCTC-DI可能有助于临床实践中评估疾病进展和短期死亡风险。
- 累积损伤与病程、mRSS、CRP浓度及EQ-5D下降相关,12个月死亡风险主要与高SCTC-DI和低EQ-5D VAS相关。
- 作者认为需要新的研究来改进SSc患者的评估工具。
研究设计与样本
- 前瞻性、单中心研究,纳入系统性硬化症(SSc)患者队列。
- 开展横断面研究及12个月纵向随访。
- 主要结局为SCTC-DI与12个月全因死亡率;其他变量包括临床实验室数据、mRSS、EQ-5D及Steinbrocker功能状态。
- 采用多因素模型研究SCTC-DI和死亡的相关因素。
主要发现
- 研究人群共75例患者(97.3%为女性),平均年龄59.6岁。
- SCTC-DI中位数(IQR)为4(6),仅4例(5.3%)患者SCTC-DI≥13(重度)。
- 与SCTC-DI相关的因素为病程(β=0.276)、mRSS(β=0.287)、C反应蛋白(CRP)浓度(β=0.311)和EQ-5D(β=-0.207)。
- 随访1年后,4例患者死亡。
- 与12个月死亡相关的因素(OR [95%CI])为基线SCTC-DI≥13(44.5 [1.6-1237.9];p=0.025)和EQ-5D视觉模拟量表(VAS)(0.9 [0.8-0.9];p=0.018)。
关键数值与推荐
- SCTC-DI中位数(IQR)为4(6)。
- 重度SCTC-DI(≥13)见于4例(5.3%)患者。
- 基线SCTC-DI≥13与12个月死亡的OR为44.5(95%CI 1.6-1237.9;p=0.025)。
- EQ-5D VAS与12个月死亡的OR为0.9(95%CI 0.8-0.9;p=0.018)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 作者指出需要新的研究来改进SSc患者的评估工具。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine cumulative organ damage in patients with systemic sclerosis (SSc) according to the Scleroderma Clinical Trials Consortium Damage Index (SCTC-DI), assess 1-year mortality risk, and identify associated factors. METHODS: A prospective, single-center study was conducted in a cohort of patients with SSc. A cross-sectional study and a 12-month longitudinal follow-up were carried out. The main outcomes were SCTC-DI and all-cause mortality at 12 months. Other variables included clinical-laboratory data, modified Rodnan Skin Score (mRSS), EuroQoL 5-D (EQ-5D), and Steinbrocker functional status. Multivariate models were used to study factors associated with SCTC-DI and mortality. RESULTS: The study population comprised 75 patients (97.3% females) with a mean age of 59.6 years. The median (IQR) of the SCTC-DI was 4(6), and only 4 (5.3%) patients had severe SCTC-DI (≥13). The factors associated with SCTC-DI were disease duration (β=0.276), mRSS (β=0.287), C-reactive protein (CRP) concentration (β=0.311), and EQ-5D (β= -0.207). After 1 year of follow-up, 4 patients had died. The factors associated with mortality at 12 months (OR [95% CI]) were baseline SCTC-DI ≥13 (44.5 [1.6-1237.9]; p = 0.025) and visual analog scale (VAS) of the EQ-5D (0.9 [0.8-0.9]; p = 0.018). CONCLUSIONS: The SCTC DI can prove useful in clinical practice for assessing disease progression and short-term mortality risk. Cumulative damage was associated with disease duration, mRSS, CRP concentration, and a decline in EQ-5D, while the risk of death at 12 months was primarily associated with high SCTC-DI and low EQ-5D VAS. New studies are needed to improve assessment tools in patients with SSc.
引用
- Cano-García L, García-Studer A, Manrique-Arija S, et al. Accrual of organ damage and one-year mortality in systemic sclerosis: A prospective observational study. Semin Arthritis Rheum. 2024. PMID: 39671728. doi:10.1016/j.semarthrit.2024.152604
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。